Success in this area means ensuring the right therapy reaches the patient in a form that is stable, effective, and ready for ...

The Synthetic Human Genome (SynHG) Project, launched on the 25th anniversary of the mapping of the human genome, is being ...

The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – has been ...

The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this ...

At BIO 2025, pharmaphorum Editor in Chief spoke with Hanadie Yousef, CEO of Juvena Therapeutics, a biotech focused on ...

The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum capturing ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

To close the innovation-access gap, there is a desperate need for an infrastructure rooted in trust. That means complementing ...

It is not clear how AS01 might help lower the risk of dementia, but Oxford University said lab studies show that the adjuvant ...

The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...

The CDC's newly constituted Advisory Committee on Immunization Practices (ACIP) has voted to recommend the removal of vaccine ...